UBS Faces Shareholder Vote and Capital Cliffhanger

UBS shareholders vote on new board, a 22% dividend increase, and face a pivotal Swiss regulatory decision that could demand billions in extra capital.

UBS shareholders are gathering in Basel for an annual meeting that arrives at a moment of profound transition. The bank is navigating a dual challenge: a significant boardroom reshuffle and an imminent regulatory decision from the Swiss government that could reshape its financial foundations. The outcomes will test the bank's strategic direction just as it reports strong post-merger operational progress.

The proposed board changes signal a clear shift in expertise. Three current directors are stepping down, with nominations for three new faces. The most prominent is Agustín Carstens, the former General Manager of the Bank for International Settlements (2017–2025) and an ex-governor of Mexico's central bank, bringing deep regulatory insight. Luca Maestri, Apple's CFO for over a decade and now its Vice President of Corporate Services, adds a profile synonymous with operational discipline and capital allocation. Markus Ronner, the bank's current Group Chief Compliance and Governance Officer, is nominated as a new Vice President, underscoring a focus on governance.

Shareholders will also vote on a proposed 22 percent dividend increase to USD 1.10 per share. This reward is backed by a robust 2025 performance, where net profit surged 53 percent to USD 7.8 billion and assets under management surpassed USD 7 trillion for the first time.

Yet overshadowing these internal moves is a pending capital requirement that could impose a multi-billion dollar burden. The Swiss Federal Council is expected to decide this April on stricter rules for systemically important banks. Finance Minister Karin Keller-Sutter has proposed that UBS must fully capitalize its foreign subsidiaries at 100 percent, up from 60 percent—a change analysts estimate could demand up to USD 26 billion in additional core capital as a response to the Credit Suisse collapse.

UBS has publicly opposed the plans, citing potential competitive disadvantages in global wealth management. However, leading parliamentarians are reportedly working on a compromise. One proposal would allow the bank to count more favorable AT1 capital toward the required buffers, potentially reducing the final burden. The definitive ordinances are expected by mid to late April.

This regulatory uncertainty has weighed on the stock, contributing to a roughly 12 percent decline since the start of the year and underperformance against peers. The shares currently trade at EUR 35.36. Despite the headwinds, Deutsche Bank Research maintains a buy recommendation with a price target of CHF 39. Analyst Benjamin Goy anticipates more clarity on the reforms this month and holds earnings estimates stable, balancing weaker wealth management trends against a stronger investment banking outlook.

Operationally, UBS continues to advance its integration of Credit Suisse. Approximately 85 percent of Swiss accounts have been migrated, with cumulative gross cost savings reaching USD 10.7 billion. Management is targeting an underlying return on CET1 capital of around 15 percent for 2026, with a medium-term goal of 18 percent.

The bank’s next major test comes swiftly after the shareholder meeting. First-quarter results for 2026 are scheduled for April 29, offering a fresh look at the bank’s health amid the regulatory suspense and a macroeconomic environment UBS itself has cautioned about, having recently lowered its S&P 500 outlook for clients due to U.S. growth and inflation risks.